BLAINJECTIONINJECTABLE
Approved
Jan 1978
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Clinical Trials (3)
Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer
Started Jan 2014
3 enrolled
Prostatic Neoplasms
Dornase Alfa and Urokinase for Kids With Pleural Empyema
Started Oct 2007
94 enrolled
Pleural Empyema
Urokinase-Plasminogen Activator (uPA) Inhibitor WX-UK1 in Combination With Capecitabine in Advanced Malignancies
Started May 2004
33 enrolled
Advanced Malignancies